Trinidad and Tobago vs Ukraine: Hepatitis B surface antigen (HBsAg) prevalence
Trinidad and Tobago
0.1%
in 2024
Ukraine
0.1%
in 2024
Trinidad and Tobago rank
101st
Ukraine rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Trinidad and Tobago
- Ukraine
How they compare
Trinidad and Tobago currently reports 0.1% against 0.1% in Ukraine, a difference of 0.0%.
Across all 10 years both countries report, Ukraine has been ahead every year.
Trinidad and Tobago ranks 101st and Ukraine ranks 101st of 194 countries.
Ukraine has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.1% | Ukraine |
| 2020s | 0.1% | 0.1% | 0.0% | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Trinidad and Tobago or Ukraine?
- Trinidad and Tobago, at 0.1% against 0.1% in Ukraine as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Trinidad and Tobago and Ukraine?
- 0.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and Ukraine?
- 10 years are reported by both, from 2015 to 2024.
- How do Trinidad and Tobago and Ukraine rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Trinidad and Tobago ranks 101st and Ukraine ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.